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Inflammation induced systemic stress plays an essential role in neoplastic progression. Chronic exposure to chemical 
carcinogens can induce persistent inflammatory changes which further augment loss in physiological hormesis of an 
organism thereby favouring carcinogenesis. The present study investigated the role of inflammation and associated systemic 
stress in the development of cervical carcinoma in a 3-methylcholanthrene (3-MC; a chemical carcinogen) induced  
in vivo cervical cancer model. When the cervix of 5-6 weeks old virgin female Swiss Albino mice (Mus musculus) was 
treated with 3-MC (0.6 mg/mL), remarkable alteration in its cervical cytopathology was observed. An increase in duration of 
3-MC treatment caused an outburst in the number and variety of infiltrating granulocytes and agranulocytes in mice cervix. 
Thus, a high leukocyte index was indicative of prevalent cervical inflammatory changes. Elevated activities of SGPT, 
SGOT, serum alkaline phosphatase enzymes along with the presence of elevated serum creatinine levels suggested liver and 
renal dysfunctions. These observations were supported by alterations in hepatic histopathology of 3-MC treated mice. 
Surged activities and expression profiles of inflammatory cytokines (IL-6 and IL-8) in cervix tissue had conclusively 
established the crucial role played by inflammation mediated systemic stress in favouring the development of cervical 
cancer in a carcinogen-induced in vivo model. 
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Systemic stress 
The concept of an intricate association between 
inflammation and cancer dates back to 19th century as 
chronic inflammation triggers mechanisms underlying 
the progression of cancer1. Proposed to be one of the 
key factors responsible for initiating the malignant 
transformation, inflammation is also termed as the 
seventh hallmark of cancer2. Chronic inflammation 
plays a crucial role in enriching the tumour 
microenvironment with prosurvival signals which 
enables the neoplastic cells to survive and proliferate 
by evading the adaptive immune response of the host 
and by developing chemoresistance3,4. Sometimes 
localized inflammation mediated by a persistent 
bacterial and viral infection can lead to increased 
cancer risk. Unremitted Helicobacter pylori infections 
of the stomach may result in gastric adenocarcinoma 
along with lymphoma of the MALT (mucosa-
associated lymphoid tissue)5,6. Although, 
inflammation can act as a “two-edged sword” 
because, in some diseases like psoriasis, the presence 
of a steadystate of inflammation helps in reducing 
the disease7,8. Conversely, carcinogens like polycyclic 
aromatic hydrocarbons (PAHs) or various aromatic 
amines render their carcinogenicity by triggering 
chronic inflammation which furthers tumorigenesis8,9. 
The whole episode of cancer related inflammation is 
dictated over by the transcription factor NF-κB and its 
relative signal transducers such as COX2, IL-6, and 
IL-810-12. These inducers of malignant transformation 
drive the process of neoplasia by bringing about 
subsequent deregulation of tumour suppressor genes 
(p53, p21, and Rb) followed by upregulation of 
proliferative markers (Ki-67 and PCNA)13,14. 
3-methylcholanthrene (3-MC), a carcinogen 
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the cancer of many organs such as skin, lungs, and 
cervix15. Cervical cancer, the 4th most leading cause of 
mortality and morbidity amongst women worldwide 
is predominantly caused by high risk human 
papilloma viruses16-18. Epidemiological reports 
suggest that PAHs can also increase cervical cancer 
risks in women19. 3-MC like other PAHs contributes 
to carcinogenicity while it gets metabolically 
activated by phase I and phase II enzymes such as 
cytochrome P-450(CYP450), catechol-O-
methyltransferase, epoxide hydrolase, peroxidases, 
glutathione S-transferases, N-acetyltransferases and 
sulfotransferases20. 3-MC metabolites such as epoxy 
derivatives mediate free radical bursts21. It induces 
excessive reactive oxygen species (ROS) and reactive 
nitrogen species (RNS) production22,23. These free 
radicals are electrophilic species which attack the 
intracellular nucleophilic moieties such as the DNA 
and glutathione and thereby promote cytotoxicity by 
induction of deleterious mutations that impair the 
repair machinery of the cells24-26. In this regard, 3-MC 
have been reported to be used for development of  
in vivo cancer models27,28. 
It is already known that cervical carcinoma 
induced by 3-MC is characterized by constitutive 
expressions of stress related biomarkers29. Based on 
these previous reports; the present study has been 
designed to investigate the role of systemic stress 
induced by persistent inflammatory mediators 
produced by chronic 3-MC treatment in Swiss 
Albino mice, while the development of an in vivo 
cervical cancer model. 
 
Materials and Methods 
Animal maintenance  
5-6 weeks old virgin female Swiss Albino mice 
(Mus musculus) weighing about 23-25 gms were 
obtained from Central Animal Facility of 
Chittaranjan National Cancer Institute (CNCI). 
These mice were kept in polyvinyl cages which were 
maintained in a well-ventilated room (temperature-
22±2C; relative humidity: 50-60%) following 12 h 
day and night cycle. The acclimatization of animals 
(mice) was carried out for 2 weeks prior to 
treatment. All female mice were kept in complete 
isolation from male mice. This aided in nullifying 
hormonal interference by bringing about pheromone 
influenced synchrony of their oestrous cycles30. All 
the animal experimentation was carried out in 
accordance with the animal ethics guidelines of the 
Institutional Animal Ethics Committee 
(IAEC,CNCI) certified by the Committee Control 
and Supervision of Experiments on Animals 
(CPCSEA), New Delhi, India. Food and water were 
given ad libitum which means  
free feeding.  
 
Experimental design 
Mice were randomized into 3 major groups; where 
6 mice were kept in each major group. Group I was 
kept as a control group which received no treatment, 
Group II was maintained as a vehicle control batch 
where mice were treated with petroleum ether (PE) 
solely, while Group III was designated to study the 
progression of cervical carcinogenesis in mice which 
underwent chronic treatment with a carcinogen 
namely 3-MC (MP Biomedicals/Fisher Scientific, 
USA) dissolved in petroleum ether for a time span of 
30 weeks, respectively. The concentration of the  
3-MC solution used for the study was 0.6 mg/mL. 
This dose of a carcinogen was selected as a safe 
dosage for treatment after dosimetry. Food and water 
were provided ad libitum to all three groups.  
The procedure followed for carcinogen treatment is 
a modification of Murphy’s String method31. The 
carcinogen solution (3-MC dissolved in petroleum 
ether) was flushed over the cervix of the animals 
belonging to group III and petroleum ether (vehicle 
solvent) to group II, respectively. During the 
continual treatment process, animals were monitored 
for possible visible health abnormalities and death. 
Animals from each of these groups were sacrificed 
intermittently (6, 12, 18, 24 and 30th week) by 
cervical dislocation followed by the collection of 
organs and blood for experimental study. All the 
experiments were repeated thrice.  
 
Record of body weight 
Weekly body weight records of animals were 
maintained to ascertain the impact of the chronic 
carcinogen treatment on their physiology.  
 
Cytopathological study 
Phosphate Buffered Saline (PBS, pH-7.4) was 
dropped on a clean grease- free glass slide on which 
cervical exfoliated cells were smeared into a thin 
conventional layer after collection. Cervical smears 
were stained as per the polychromatic staining method 
of the Papanicolaou staining (Pap staining) process32. 
The cell smears were fixed in 100% ethyl alcohol 
followed by subsequent staining with Harris 




Haematoxylin (HH), Orange G6 (OG6) and Eosin 
Azure (EA50) [Merck Millipore, Mumbai, India]. 
Excess haematoxylin stain was removed by rinsing 
the slides in tap water whereas an excess of OG6 and 
EA50 was washed in 70% and 90% alcohol, 
respectively followed by clearance in 100% ethyl 
alcohol and xylene. Thereafter the slides  
were mounted and observed under a light  
microscope (Zeiss). 
 
Enumeration of leukocyte index 
A leukocyte index was prepared by calculating the 
ratio of the number of leukocytes observed to the total 
number of cervical exfoliated cells present in a 
particular field of the Pap smear for each treatment. 
More than 20 fields were examined for each slide and 
data were recorded to enumerate leukocyte index (LI), 
LI = [(number of leukocytes observed/total number of 
cervical exfoliated cells)]. The study of the differential 
subpopulations of leukocytes infiltrating the cervical 
region during the treatment course was also performed. 
 
Estimation of liver enzymes  
The hepatic toxicity induced because of chronic 
carcinogen treatment was assessed by estimating 
serum SGOT, SGPT, and alkaline phosphatase by 
using AUTOSPAN liquid stable kits33,34. After the 
sacrifice of mice, blood was withdrawn from the 
heart’s ventricular apex using a syringe and collected 
in serum separating vials. The serum was separated 
from blood using these vials.  
 
Estimation of serum creatinine 
Serum creatinine levels were measured by Jaffe’s 
method35. The results were expressed in terms of fold 
increase in creatinine levels so that a comparative study 
can be made. All the experiments were repeated thrice.  
 
Quantification of IL-6 and IL-8 in cervix tissue lysate 
Cytokines, IL-6 and IL-8 were determined by using 
the cervical tissue lysates by using commercially 
available ELISA kits (Invitrogen). The optical density 
of the coloured solution was measured using the 
ELISA reader (TECAN) at 450 nm. The results were 
recorded against a standard blank. The experiment 
was repeated thrice.  
 
Western Blot analysis 
Lysates from cervix tissue were used to measure 
the expression of IL-6 and IL-8 by Western blotting 
using specific antibodies. The concentration of 
proteins of cervical tissue lysates of both normal and 
tumour bearing mice was estimated by Lowry’s 
method. Electrophoresis through 12.5% SDS-
polyacrylamide gels was performed where 50 μg of 
total protein was loaded into each well using an 
electrophoresis buffer (25 mM Tris, 192 mM glycine, 
10% SDS) within the electrophoretic chamber. The 
separated proteins were electrotransferred to 
nitrocellulose membranes using transfer buffer  
(250 mM Tris, 192 mM glycine, 10% Methanol). 
After proper blocking with bovine serum albumin 
(BSA), membranes were washed properly with Tris 
Buffered Saline (TBS) pH-7.5 containing 25 mM 
Tris-HCl and 150 mM NaCl followed by incubation 
with primary antibodies overnight at 4C with 
constant shaking. The blots were washed 4 times with 
TBST Buffer (40 mL TBS and 20 µL Tween-20) 
solution following incubation with secondary 
antibodies conjugated with alkaline phosphatase 
enzyme (1:1000 dilutions in TBST) at 4C for 2 h. 
Membranes were then washed 4 times and incubated 
with the substrate (BCIP/NBT) to visualize the proteins 
in dark. These experiments were repeated thrice. 
 
Histopathological study 
Liver tissue was dissected out and washed in cold 
normal saline (0.87%). This was fixed in 10% Neutral 
Buffered Formalin (NBF) for 24 h after which it was 
processed through grades of alcohol and xylene 
followed by paraffin embedding for 1hr. Later, this 
embedded tissue was taken for paraffin block 
preparation followed by microtomy. Tissue sections 
of 5 μM thickness were made using microtome and 
stretched over a glass slide which was taken for 
haematoxylin and eosin staining after removal of 
paraffin in xylene followed by treatment in ascending 
and descending grades of alcohol36. After staining the 
sections, these slides were immersed in xylene 
following which they were mounted and examined 
under a light microscope (Zeiss).  
 
Statistical analysis 
Statistical analysis was carried out using GraphPad 
Prism Software. A Comparison between the three 
groups was done by ANOVA, followed by the 
student’s t-test. A P-value <0.005 was considered 
statistically significant.  
 
Results 
Effect of carcinogen treatment on the body weight of the 
animals 
Chronic treatment with 3-MC resulted in gradual 




loss in bodyweight of mice. This observation was noted 
for up to 12 weeks of treatment. As the treatment 
duration reached 16 weeks, a conspicuous rise in the 
body weight was observed which was maintained till 
30 weeks of carcinogen treatment (Fig. 1). No such 
fluctuation was observed in the bodyweight of the mice 
of control and vehicle control batches. 
 
Effect of 3-MC on infiltrating inflammatory cells in the cervix 
Pap smear test with cervical swabs revealed that 
treatment of mice with 3-MC in a chronic fashion for 
30 weeks caused infiltration of various multitudes of 
inflammatory mediators such as granulocytes and 
agranulocytes in their cervical region. During the 
initial phase of 3-MC treatment, eosinophils were 
sparsely present with a LI ratio of 4±0.2 and thus 
exhibited no significant alteration for batch (Fig. 2A 
& D). As treatment duration reached 12 weeks, 
neutrophils appeared in excessive numbers with a 
significantly high LI ratio of 8.5±0.176 in comparison 
to control mice (Fig. 2B & D). Monocytes joined the 
milieu of infiltrating cervical leukocytes when the 
carcinogen treatment reached 24 and 30 weeks, 
respectively (Fig. 2C). The LI ratio during the 24th 
week of 3-MC treatment was found to be as high as 
10.2±0.34 and it remained almost unchanged with a 
little significant rise (11.8±0.18) during the 30th week. 
Although when compared to control and vehicle 
control groups, these LI values for both 24th week and 
30th week were found to be extremely high. However, 
the LI value of the vehicle control group exhibited no 
significant difference with that of the control batch 
indicating the absence of any contribution of PE in 
inducing inflammation in the mice cervix (Fig. 2D). 
Furthermore, increased treatment duration conciliated 
an increase in the total count of leukocyte infiltrating 
the cervix (Fig. 2D). This indicated that 3-MC 
induced persistent inflammatory changes in the cervix 
might have paved the way for cervical carcinogenesis. 
 
Activity and expression of inflammatory mediators (IL-6 and 
IL-8) in the cervix tissue during carcinogenic progression 
Owing to the increased infiltration of leukocytes 
observed in the cervix of 3-MC treated mice, the 
activity of IL-6 and IL-8 was studied. The subsequent 
rise in IL-6 and IL-8 activity was found in the cervix 
with an increase in treatment duration (Fig. 3A). 
These cytokines are essential for the maturation and 
differentiation of neutrophils. Activities of both the 
cytokines (IL-6 and IL-8) were found to rise 6th week 
onwards of 3-MC treatment in comparison to 
untreated control (Fig. 3A). A surge in IL-6 activity in 
the cervix of animals with a fold increase value of 
81.2±0.73 was noted during the 24th week of 
treatment while an escalation of 79.7 ±0.40 in IL-8 
fold increase activity was found during 18th week of 
treatment (Fig. 3A). No significant alteration in IL-6 
and IL-8 activity was however observed (IL-6 fold: 
3.9±0.193; IL-8 fold: 5.2 ±0.09) in control animals. 
IL-6 and IL-8 activities were extremely high in the 
mice cervix which had received 30 weeks of 3-MC 
 
Fig. 1 — Trends in body weight fluctuations as represented 
graphically. Mice treated with 3-MC underwent gradual loss in 
body weight till 12th week followed by a gain in body weight. The 
appearance of tumour near the cervix was observed in most of the 
treated mice after on an average of 16th week of treatment 
 
Fig. 2 — Differential subpopulations of leucocytes infiltrating the cervical region during chronic 3-MC treatment as observed in Pap 
smear. (A) appearance of eosinophils in the cervix during initial phase of treatment; (B) increased infiltration of neutrophils during 12 
weeks of 3-MC treatment; (C) emergence of monocytes alongside neutrophils during 24-30 weeks of 3-MC treatment; and (D) Graphical 
representation of leucocyte index (LI) as calculated as the ratio of number of leucocytes observed to the total number of exfoliated cells 
present in each field of Pap Smear. Values are mean ± SD, (n=6). P* <0.005 and P** <0.0001 vs untreated control batch 
 




treatment (Fig. 3A). 
Western Blot analysis to study the expressions of 
IL-6 and IL-8 from the isolated cervix tissues of both 
normal and tumour bearing mice were performed to 
ascertain the putative role played by these cytokines 
in carcinogenic progression (Fig. 3B). In control and 
vehicle control group expression profiles of IL-6 and 
IL-8 were very poor, which increased concomitantly 
with increased treatment duration in the treated group 
(Fig. 3B). Expression profiles of both IL-6 and IL-8 
strongly corroborated with the activities of  
these cytokines. 
 
Liver dysfunction during carcinogenic progression  
The next objective of the study is to ascertain 
whether chronic exposure to 3-MC led to distorted 
liver function in treated mice. Biochemical assays like 
an estimation of SGPT and SGOT were carried out 
using kits. The results were expressed as IU/L which 
is the product of a change in absorbance of the sample 
per minute and kinetic factor (provided along with the 
kit protocol). An uprising trend of SGPT and SGOT 
enzyme activities were observed after 4 to 5 weeks of 
3-MC treatment, which were found to surge 
significantly (SGPT: 12.3 IU/L±0.261; SGOT:  
20.62 IU/L±0.759) by 6th week of 3-MC treatment 
onwards to control (Fig. 4A). This escalation of 
enzymatic activities exhilarated as the treatment 
process progressed through 12th-16th week, eventually 
reaching to stasis by 24th to 30th weeks (Fig. 4A). On 
the contrary, no significant change was observed 
between the SGPT and SGOT kinetics of vehicle 
control and control animals (Fig. 4A).  
High SGPT and SGOT activities were found to be 
coherently associated with the alterations in hepatic 
histopathology of 3-MC treated animals (Fig. 4B & 
C). The presence of inflammatory infiltrates alongside 
clusters of necrotic hepatocytes and damaged portal 
tract with bile duct proliferation and marked atypia 
was well noted in the liver histological sections 
obtained from animals that had received 30 weeks of 
3-MC treatment (Fig. 4B). Normal central veins were 
observed in liver sections from the untreated control 
group with no evidence of hepatocyte injury, fibrosis 
or dysplasia and malignancy (Fig. 4C). 
 
Serum Alkaline phosphatase enzyme activity  
A gradual increase in serum alkaline phosphatase 
(ALP) enzyme activity with an increase in the duration 
of 3-MC treatment was observed. There was no change 
in the serum enzyme activity documented during the 
initial 6 weeks of 3-MC treatment to control mice  
(Fig. 5A). During the 12th week, the serum alkaline 
phosphatase kinetics for treated mice was recorded as 
3.4 IU/L±1.032. This was extremely higher when 
compared to control mice. A significant increase in 
enzyme activity was apparent when treatment duration 
was increased from 12 weeks to 30 weeks (Fig. 5A). 
Alkaline phosphatase enzyme activity for vehicle 
control and control batches conversely exhibited no 
significant alteration (Fig. 5A). 
 
Estimation of serum creatinine levels 
Chronic 3-MC treatment till 30 weeks led to 
impairment of renal function as comprehended from 
the presence of high levels of serum creatinine. 
Consistent elevation in the level of serum creatinine 
was found to be maintained in treated groups between 
12 to 30 weeks of treatment (Fig. 5B). During the 
initial phase of treatment of up to 6 weeks, no 
significant change in serum creatinine level was 
observed in comparison to control mice. Changes 
were found to be gradual with a subtle significant fold 
increase in serum creatinine levels by 2.4 ±0.072 
 
Fig. 3 — Activity and expression profiles of IL-6 and IL-8 in 
control mice and mice group subjected to chronic 3-MC treatment 
at the cervix. (A) IL-6 and IL-8 levels from cervical tissue lysates. 
Values represent mean ±SD (n=3). P* <0.005 and P** <0.0001 vs
controls; and (B) Protein expression of IL-6 and IL-8 as observed 
by western blotting. Lane 1: control batch, lane 2: vehicle control, 
lane 3: 3-MC treatment for 6 weeks, lane 4: 3-MC treatment for 
12 weeks, lane 5: 3-MC treatment for 18 weeks, lane 6: 3-MC 
treatment for 24 weeks, lane 7: 3-MC treatment for 30 weeks 
(tumor- bearing cervix), lane 8: corticomedullary region of the 
tumor obtained after 30 weeks, lane 9: richly vasculated 
medullary region of the tumor. β-actin was used as a control to 
ensure equal protein loading 




being documented in the 12th week of 3-MC treatment 
(Fig. 5B). Creatinine levels in the serum obtained 
from the mice of vehicle control and control batches 
did not exhibit any difference (Fig. 5B). 
 
Discussion 
Metabolic transformation is a prerequisite for  
3-MC to mediate the process of carcinogenesis in an 
organism. Like other PAHs, 3-MC also gets 
metabolized by the liver CYP450 leading to the 
generation of electrophilic moieties which induces 
DNA damage. Administration of 3-MC in in vivo 
model of cervical cancer was although limited only to 
the cervical region, its effect was not only 
conspicuous in the cervix but also in other organs. 
Evidence to this fact has been recorded in terms of 
 
 
Fig. 4 — (A) Serum SGPT and SGOT levels in control, vehicle and 3-MC treated groups. *P <0.005 and **P <0.0001 vs controls; (B) 
Histological (H & E staining) observation of liver from the untreated control group, showing normal hepatic architecture; and (C) 
Abnormal histopathology showing deformed central vein, damaged portal tract, remarkable atypia, and dysplasia after treatment with 3-




Fig. 5 — (A) Serum alkaline phosphatase kinetics; and (B) serum creatinine level estimation. Values (mean ± SD) for both the parameters 
measured in the serum of mice treated chronically with 3-MC at 0, 6, 12, 18, 24 and 30 weeks. **P <0.001 vs control 




gradual loss in body weight of the treated mice 
particularly till the 12th week of 3-MC treatment. 
Since the treatment was made on a chronic basis, the 
accumulation of 3-MC metabolites might have 
intervened into the normal metabolic trends of these 
mice. This had driven the process of tumorigenesis in 
the cervix by the 24th week of 3-MC treatment. As the 
treatment progressed to 16 weeks, there was a gain in 
body weight observed which continued till the 30th 
week of treatment.  
The high rate of infiltration of leukocytes in the 
cervical region indicated the initiation and prevalence 
of inflammation. The presence of neutrophils in large 
numbers had played an important role in the 
development of cervical cancer in mice due to chronic 
3-MC treatment. High numbers of neutrophil in blood 
in comparison to other leukocytes are considered to 
be a vital factor for cancer prognosis37. Neutrophils 
are the major drivers of localized inflammation which 
releases chemoattractants for other inflammatory 
cells38. In this study appearance of monocytes during 
the later phases of 3-MC treatment is also suggestive 
of the role played by neutrophil in the maintenance of 
induced inflammation. This remodelled the cervical 
niche to allow neoplastic growth. 
During the developmental stages of in vivo model, 
inflammation- mediated carcinogenesis was found to 
be associated with higher expression profiles of IL-6 
and IL-8 as obvious from western blot results. 
Activities of these cytokines in the cervix tissue 
lysates were also found to be quite high. In HPV-16 
mediated cervical carcinogenesis, IL-6 titres are found 
to be comparatively higher in invasive cervical 
carcinoma stages than in precursor lesions39,40. IL-6 
strengthens the scenario of inflammation by fostering 
monocyte chemoattractant protein-1 which helps in 
recruiting monocytes to the site of malignancy41. This 
signalling axis further activates IL-8 which is also 
known as neutrophil-activating factor. A community 
signalling loop including IL-6, IL-8, and other 
inflammatory mediators get formed thereby making 
the scenario of inflammation more fierce42. In HPV 
mediated cervical carcinogenesis, compelling 
evidence suggest the mediating the generation of 
oxidative stress helps to mediating the overactivity of 
these cytokines that induce cervical 
carcinogenesis43,44. Similar prosurvival signalling 
might have got manifested in the present study 
during the development of the in vivo model of 
carcinoma which might be due to a long period of 
subjection to stress owing to which higher frequency 
of granulocyte and agranulocyte infiltration was 
observed in the cervical region. Various reports 
suggested that excerbating levels of inflammatory 
cytokines are necessary for progression of cervical 
cancer as well as for other cancers like colorectal 
cancers45-47. 
Metabolism of 3-MC always takes place in the liver 
microsomes48. Thus, excess of carcinogen-induced 
stress can lead to distorted liver function. This serves as 
an important factor that contributes to the development 
of conditions favouring the establishment of 
carcinoma. Major determinants of liver function are 
SGPT, SGOT and ALP49-51. High serum SGPT, SGOT 
and ALP levels as observed in the present findings 
indicate despaired liver function which helps in 
assessing the impact of the stress- induced by 
carcinogen on the physiology of the treated mice. In 
case of development of an in vivo carcinoma model, 
determination of SGPT, SGOT, and ALP levels in the 
serum not only aids in understanding the extent of 
induced systemic stress but also provides a tool to 
select the sublethal dosage of carcinogen for 
treatment52,53. Several other researchers have 
authenticated that administration of carcinogen to mice 
in a chronic fashion, can induce necessary hepatic 
toxicity which can serve as a prerequisite to continue 
the process of carcinogenesis54,55. Biochemical changes 
were found to be coherently associated with the 
histological architecture of the liver obtained from the 
same groups of mice. On the other hand, the presence 




All these results cumulatively indicated that 
chronic carcinogen treatment resulted in the induction 
of a prolonged inflammatory state in the cervix. This 
acted as an additive stressor for augmenting the loss 
of physiological homeostasis in the treated mice. 
Localized treatment of the cervix with 3-MC 
ultimately culminated in impairment of functions of 
vital organs like liver and kidney. Thus carcinogenic 
progression in the cervical carcinoma model in vivo is 
the resultant of the interplay of different inflammatory 
stressors within the system.  
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